Bente Glintborg

Bente Glintborg

Clinical Associate Professor

Member of:

  • Internal Medicine: Rheumatology


Publication year:
All
51 - 60 out of 75Page size: 10
  1. 2020
  2. Published

    Intake of dietary fibre, red and processed meat and risk of late-onset chronic inflammatory diseases: A prospective Danish study on the “diet, cancer and health” cohort

    Rubin, K. H., Rasmussen, N. F., Petersen, I., Kopp, T. I., Stenager, E., Magyari, M., Hetland, Merete Lund, Bygum, A., Glintborg, Bente & Andersen, V., 2020, In: International Journal of Medical Sciences. 17, 16, p. 2487-2495 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. 2019
  4. Published

    Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

    Canet, L. M., Sánchez-Maldonado, J. M., Cáliz, R., Rodríguez-Ramos, A., Lupiañez, C. B., Canhão, H., Martínez-Bueno, M., Escudero, A., Segura-Catena, J., Sorensen, S. B., Hetland, M. L., Soto-Pino, M. J., Ferrer, M. A., García, A., Glintborg, B., Filipescu, I., Pérez-Pampin, E., González-Utrilla, A., Nevot, M. Á. L., Conesa-Zamora, P. & 10 others, Broeder, A. D., De Vita, S., Jacobsen, S. E. H., Collantes-Estevez, E., Quartuccio, L., Canzian, F., Fonseca, J. E., Coenen, M. J. H., Andersen, V. & Sainz, J., 2019, In: The Pharmacogenomics Journal. 19, 1, p. 83-96 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Risk factors for Staphylococcus aureus bacteremia in patients with rheumatoid arthritis and incidence compared with the general population: Protocol for a Danish nationwide observational cohort study

    Dieperink, S. S., Glintborg, Bente, Oestergaard, L. B., Nørgaard, M., Benfield, Thomas, Mehnert, F., Petersen, A. & Hetland, Merete Lund, 2019, In: BMJ Open. 9, 9, 7 p., e30999.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs?

    Glintborg, Bente, Ibsen, R., Bilbo, R. E. Q., Hetland, Merete Lund & Kjellberg, J., 2019, In: RMD Open. 5, 2, 9 p., e001016.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    To switch or not to switch: Results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

    Glintborg, B., Loft, A. G., Omerovic, E., Hendricks, O., Linauskas, A., Espesen, J., Danebod, K., Jensen, D. V., Nordin, H., Dalgaard, E. B., Chrysidis, S., Kristensen, S., Raun, J. L., Lindegaard, H., Manilo, N., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard Pedersen, D., Sørensen, I. J., Andersen, L. S. & 4 others, Grydehøj, J., Mehnert, F., Krogh, N. S. & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, 2, p. 192-200

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

    Grøn, K., Glintborg, Bente, Nørgaard, M., Mehnert, F., Stergaard, M., Dreyer, L., Krogh, N. S., Bjørner, Jakob Bue & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 1391-1391 SAT0595.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  9. Published

    OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB: AN OBSERVATIONAL COHORT STUDY

    Grøn, K., Glintborg, Bente, Mehnert, F., Østergaard, Mikkel, Dreyer, L., Nørgaard, M., Krogh, N. S. & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 630 THU0667.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  10. Published

    Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial

    Grøn, K. L., Glintborg, Bente, Nørgaard, M., Mehnert, F., Østergaard, Mikkel, Dreyer, L., Krogh, N. S., Bjørner, Jakob Bue & Hetland, Merete Lund, 2019, In: Arthritis & Rheumatology. 71, 12, p. 1997-2004 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

    Grøn, K. L., Arkema, E. V., Glintborg, Bente, Mehnert, F., Østergaard, Mikkel, Dreyer, L., Nørgaard, M., Krogh, N. S., Askling, J. & Hetland, Merete Lund, 2019, In: Annals of the Rheumatic Diseases. 78, 3, p. 320-327

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study

    Højgaard, P., Ellegaard, K., Nielsen, S. M., Christensen, R., Guldberg-Møller, J., Ballegaard, C., Dreyer, L., Mease, P., de Wit, M., Skov, Lone, Glintborg, Bente, Bliddal, Henning, Bartels, E. M., Amris, K. & Kristensen, L. E., Jun 2019, In: Arthritis Care & Research. 71, 6, p. 798-810 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 7 8 Next

ID: 212553036